MedPath

The effectiveness of intravenous lidocaine to reduce coughing during laryngeal mask airway insertio

Phase 4
Conditions
General anesthesia with laryngeal mask airway insertion
Intravenous lidocaine, Laryngeal mask airway
Registration Number
TCTR20221207002
Lead Sponsor
Khon Kaen University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
74
Inclusion Criteria

Patients undergo elective surgery under general anesthesia with laryngeal mask insertion

Exclusion Criteria

1.Risk aspiration
2.Protocol drugs allergy
3.Coronary artery disease or arrhythmia
4.Cerebrovascular disease
5.BMI > 30 kg/m2
6.Respiratory tract infection within 2 week
7.Heavy smoking
8.Suspected difficult airway

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Coughing During LMA insertion Number
Secondary Outcome Measures
NameTimeMethod
Total propofol During LMA insertion Mean SD or Median (IQR),Movement During LMA insertion Number,Attempt of LMA insertion During LMA insertion Number,Laryngospasm During LMA insertion Number,Gagging During LMA insertion Number,Hiccup During LMA insertion Number,Heart rate Before, 1, 3, 5, 10, 15 after LMA insertion Mean (SD) or median (IQR),Blood pressure Before, 1, 3, 5, 10, 15 after LMA insertion Mean (SD) or median (IQR),Desaturation During LMA insertion Number
© Copyright 2025. All Rights Reserved by MedPath